CDKN2A and leukemia: Together, losses of CDKN2A/B, RB1 and PAX5 reconcile how Late-Pro leukemias escape the pre-B cell receptor checkpoint and maintain a proliferative state (Supplementary Fig. 6, bottom, and Extended Data Fig. 5f)25.